Skip to main content

W. P. Carey Inc.

For the period ended Jun 13, 2024. Filed Mar 28, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 13, 2024 · Filed Mar 28, 2024

WPC$65.05-0.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

10 2024 Proxy Statement

Professional Experience■BentallGreenOak: Managing Partner and Member of the Global Investment Committees (since 2011)■W. P. Carey Inc.: Non-Executive Chair of the Board (since June 2019), Non-Executive Vice Chair of the Board (2018–June 2019)■International Council of Shopping Centers: Trustee (since 1996)■Morgan Stanley Real Estate: Vice Chairman (2006–2010)■Morgan Stanley: Head of Global Real Estate Investment Banking (1994–2006)Other Current Public Company Boards■NoneQualificationsMr. Niehaus brings over four decades of experience in the real estate industry and a broad range of experience in finance, real estate investment banking, portfolio management and private equity, as well as public, private and international fund raising and fund management. He has served on the boards of private equity real estate companies in the U.S., Europe and Asia. Mr. Niehaus is a Managing Partner of BentallGreenOak, a global real estate investment management firm with over $80 billion of assets under management. Previously, he spent almost three decades at Morgan Stanley building and running one of the leading global real estate banking, lending and investing businesses bringing invaluable experience to his role as Non-Executive Chair of the Board.Independent DirectorSince 2016W. P. Carey CommitteesInvestment (Chair), Nominating and Corporate Governance
International Business ExperienceM&A IntegrationU.S. Public Company Executive Officer ExperienceReal Estate Expertise
Public & Private Capital Markets ExpertiseInvestor RelationsDiversity, Equity & Inclusion

2024 Proxy Statement 11

Elisabeth T. Stheeman, 60
Independent DirectorSince 2022W. P. Carey CommitteesInvestment, Nominating and Corporate GovernanceProfessional Experience■Asian Infrastructure Investment Bank – Multilateral Development Bank: External Member of Audit and Risk Committee (since April 2021)■German British Chamber of Industry and Commerce: Member of Council (since 2016)Former Boards: Bank of England: External Member of Financial Policy Committee (2018–February 2024) and Financial Market Infrastructure Board (2017–December 2023); London School of Economics: Member of Council and Finance & Estates Committee (2016–August 2023); alstria office REIT-AG: (ETR:AOX) Member of the Supervisory Board, Investment Committee, and Nominations and Remunerations Committee (May 2021–May 2023); Aareal Bank AG Supervisory Board Member 2015–August 2022; Korian SA Independent Non-Executive Director 2017–June 2019; TLG Immobilien AG Non-Executive Director 2014–2018Other Current Public Company Boards■Edinburgh Investment Trust PLC: (FTSE: EDIN) Chair (since July 2022), Non-Executive Director (since May 2019)QualificationsMs. Stheeman brings to the Board a wealth of experience in financial services, private equity, real estate and healthcare in the UK, Germany and France. Before joining the Bank of England, she developed deep capital markets and real estate understanding through her role as Global Chief Operations Officer at LaSalle Investment Management and in her nearly 25-year executive career at Morgan Stanley. Her extensive board experience in the REIT industry provides a considerable source of knowledge and insight to the Board.
International Business ExperienceM&A IntegrationReal Estate ExpertisePublic & Private Capital Markets Expertise
Investor RelationsDiversity, Equity & InclusionInformation Technology & CybersecurityEnvironmental, Social and Governance
Human Capital ManagementLegal & Compliance
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.